Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, New York, NY USA.
Isr J Health Policy Res. 2014 Dec 18;3(1):42. doi: 10.1186/2045-4015-3-42. eCollection 2014.
PIGD for gender selection for non medical reasons has been a subject of ethical, legal, and moral debate in many Western countries. This article discusses the background of elective sex selection, and highlights the impact of new technological developments on this dynamic discussion. The article published by Pessach et al., in this Journal, is an excellent study of Israeli health policy on non medically indicated preimplantation genetic screening for sex selection. In Israel, elective sex selection is prohibited, but exceptions can be made by application, for family balancing, and emotional and religious reasons. This review of a health policy over seven years is concordant with evolving views in many Western countries. The classic medical model for allowing sex selection for serious medical disorders may be too restrictive. There are different reasons that may be assessed in light of ethical criteria including a wider delineation of medical reasons, which may include emotional and psychological well being of the family, indirect medical reasons, as well as risk reduction for the following generations. The Israeli model may be a useful approach with wide application to reproductive health policies in many countries.
出于非医疗原因选择性别（PGD）在许多西方国家一直是一个伦理、法律和道德争论的主题。本文讨论了选择性性别选择的背景，并强调了新技术发展对这一动态讨论的影响。Pessach 等人在本刊发表的文章是对以色列非医疗指征的胚胎植入前遗传学筛查选择性别健康政策的优秀研究。在以色列，选择性性别选择是被禁止的，但可以通过申请，出于家庭平衡以及情感和宗教原因获得例外。对七年来的一项卫生政策进行审查与许多西方国家不断变化的观点是一致的。经典的医学模式允许为严重的医疗疾病选择性别可能过于严格。可能根据伦理标准评估不同的原因，包括更广泛的医疗原因定义，这可能包括家庭的情感和心理健康、间接医疗原因，以及为后代减少风险。以色列模式可能是一种有用的方法，适用于许多国家的生殖健康政策。
